Date: 27.8.2018
Summary:
A Dutch clinical stage company is developing a new generation of nanomedicines. Their aim is to use their nanoparticle technology to improve the efficacy and safety profiles of current and novel drugs for the treatment of solid tumours.
As part of their development strategy, they are looking for a license and/or technical cooperation agreement with academic research labs to exploit their nanoparticles for enhanced tumour targeting of new oligonucleotides with therapeutic potential.
Reference: TRNL20180531001
Country: Netherlands
Submitted: 27. 8. 2018
Keywords
Technology: Clinical Research, Trials, Cytology, Cancerology, Oncology, Medical Research, Pharmaceutical Products / Drugs
Market: Drug delivery and other equipment, Oncology, Pharmaceuticals/fine chemicals
NACE: Research and experimental development on biotechnology, Other human health activities
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Brigady pro studenty - Brigady pro studenty
Brno University of Technology - university of technology in Brno
Say hello to biodegradable microplastics: Plant-based polymers that can disappear within seven months
Synthetic antibody could be key to a universal antivenom